C. David James

机构: Professor Emeritus, Feinberg School of Medicine, Northwestern University

主页: northwestern.edu

每年引用次数

引用次数

引用: 45,020

H-指数: 104

I10-指数 : 247

出版物: 567

Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia.

H. W. Findley , L. Gu , S. D. Smith , J. He
Leukemia 9 ( 7) 1159 -1161

14

1995

Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.

N. Longo , J. J. Olson , M. L. Hamid , A. J. Ekstrand
Oncogene 9 ( 8) 2313 -2320

239

1994

RT-PCR detection of mRNA recovered from archival glass slide smears.

D. A. Akoury , C. D. James , J. J. Seo , S. R. Zaki
Modern Pathology 6 ( 2) 195 -200

14

1993

Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor

N. Longo , V. P. Collins , A. J. Ekstrand , M. L. Hamid
Oncogene 10 ( 7) 1455 -1460

56

1995

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

N. Sugawa , A. J. Ekstrand , C. D. James , V. P. Collins
Proceedings of the National Academy of Sciences of the United States of America 87 ( 21) 8602 -8606

711

1990

Mitotic recombination of chromosome 17 in astrocytomas.

C. D. James , E. Carlbom , M. Nordenskjold , V. P. Collins
Proceedings of the National Academy of Sciences of the United States of America 86 ( 8) 2858 -2862

249

1989

Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma

C. K. Cheng , W. C. Gustafson , E. Charron , B. T. Houseman
Proceedings of the National Academy of Sciences of the United States of America 109 ( 31) 12722 -12727

27

2012

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240

T. R. Fenton , D. Nathanson , C. Ponte de Albuquerque , D. Kuga
Proceedings of the National Academy of Sciences of the United States of America 109 ( 35) 14164 -14169

118

2012

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

J. S. Smith , I. Tachibana , S. M. Passe , B. K. Huntley
Journal of the National Cancer Institute 93 ( 16) 1246 -1256

511

2001

Molecular Genetics of Oligodendroglial Tumors

G. Reifenberger , J. Reifenberger , L. Liu , C. D. James
Brain Tumor 187 -201

8

1996

Noninvasive detection of target modulation following phosphatidylinositol-3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy

C. S. Ward , H. S. Venkatesh , M. M. Chaumeil , A. H. Brandes
Cancer Research 70 ( 4) 1296 -1305

126

2010

p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.

E. B. Dinca , K. V. Lu , J. N. Sarkaria , R. O. Pieper
Cancer Research 68 ( 24) 10034 -10039

33

2008

SC-16DIVERGENT CELL CYCLE REGULATION IN GBM CELLS PROVIDES A UNIQUE POINT OF INTERVENTION IN POLARIZED CD133+ CELLS.

T. Ozawa , C. D. James , l. Petritsch , R. Lerner
Neuro-oncology 16

2014

Protein kinase A–dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α

H. Feng , Y. Li , Y. Yin , W. Zhang
Neuro-oncology 17 ( 6) 832 -842

12

2015

BT-07MEASURING TUMOR METABOLISM IN DIFFUSE INTRINSIC PONTINE GIOMAS (DIPG) USING HYPERPOLARIZED CARBON-13 MR SPECTROSCOPIC IMAGING

I. Park , R. Hashizume , X. Yang , P. Larson
Neuro-oncology 17

2015

TR-08TARGETED COMBINATORIAL APPROACH FOR TREATMENT OF PEDIATRIC LOW GRADE GLIOMAS IN THE CONTEXT OF BRAFV600E AND KIAA1549:BRAF MUTATIONS

A. K. Olow , S. Mueller , X. Yang , R. Hashizume
Neuro-oncology 17

2015

HG-13SOX9 AS A DOWN-STREAM TARGET IN RAS/MEK-DRIVEN PEDIATRIC GLIOMA

G. I. Evan , E. Y. Snyder , W. A. Weiss , A. I. Persson
Neuro-oncology 17 13 -13

2015

HIGH INTERSTITIAL FLUID PRESSURE REGULATES TUMOR GROWTH AND DRUG UPTAKE IN HUMAN GLIOBLASTOMA

A. I. Persson , S. Ilkhanizadeh , Y. A. Miroshnikova , A. Frantz
Neuro-oncology 16

1

2014

RB1 SUPPRESSION IS RESPONSIBLE FOR ACQUIRED CDK4/6 INHIBITOR RESISTANCE IN GLIOBLASTOMA

C. D. James , Y.-J. Lu , T. Ozawa , M. D. Prados
Neuro-oncology 16

2014

BIOLOGICALLY-BASED THERAPEUTICS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS

N. Gupta , R. Hashizume , N. Andor , Z. Zhang
Neuro-oncology 16

2014

cancer research